Renal tumors, renal tuberculosis, and polycystic kidney disease.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Sex: no restriction; 2. Age: 18-70 years; 3. BMI: 18-28 kg/m^2; 4. ASA: I-III.
Exclusion criteria
Exclusion criteria: 1. Patients with allergy to the study drug (e.g., ropivacaine); 2. Patients with infection, ulceration, or skin disease within 5 cm of the puncture site; 3. Patients with coagulation disorders or currently receiving anticoagulant therapy; 4. Patients on long-term analgesic therapy; 5. Patients with severe hepatic or renal insufficiency; 6. Patients with severe cardiovascular disease; 7. Patients with a clear history of neurological disease; 8. Patients with psychiatric disorders or cognitive impairment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative intravenous morphine equivalent within 48 hours; | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative indicators:Type of surgery;surgical site;operative time;tumor size;NRS scores at 2, 6, 12, 24, and 48 hours after surgery; QoR-15 score; | — |
Countries
China
Contacts
Ningbo Medical Centre Lihuili Hospital